Covalon Technologies Ltd. ( CVALF) - Key Metrics
CVALF Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q3 | $0.36 | $0.10 | $0.10 | $0.09 |
| 2026Q2 | $0.32 | $0.04 | -$0.04 | -$0.05 |
| 2026Q1 | $0.25 | $0 | $0.21 | $0.18 |
| 2025Q4 | $0.32 | $0.01 | -$0.02 | -$0.02 |
| 2025Q3 | $0.31 | $0 | $0.08 | $0.06 |
CVALF Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q3 | 0% | 5.29 |
| 2026Q2 | 0% | 11.39 |
| 2026Q1 | 3304.22% | 94.52 |
| 2025Q4 | 0% | 40.64 |
| 2025Q3 | 0% | 256.44 |
CVALF Free Cash Flow Yield and Dividend Yield
| Date | Free Cash Flow Yield | Dividend Yield |
|---|---|---|
| 2026Q3 | 4.37% | 0% |
| 2026Q2 | -2.66% | 0% |
| 2026Q1 | 10.86% | 8.82% |
| 2025Q4 | -0.96% | 0% |
| 2025Q3 | 2.54% | 0% |
CVALF
Price: $2.70
52 week price:
Dividend Yield: 4.45%
Earnings Per Share: 0.05 USD
P/E Ratio: 27.60
Exchange: OQX
Sector: Healthcare
Industry: Biotechnology
Market Capitalization: 66.0 million